Bio-Thera Solutions Ltd Cash Flow Conversion Efficiency

Latest as of June 2023: -0.054x

Bio-Thera Solutions Ltd cash flow conversion efficiency. Based on the latest financial reports, Bio-Thera Solutions Ltd (688177) has a cash flow conversion efficiency ratio of -0.054x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-72.53 Million ≈ $-10.61 Million USD) by net assets (CN¥1.35 Billion ≈ $198.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Bio-Thera Solutions Ltd (2016–2025)

Cash flow conversion efficiency of Bio-Thera Solutions Ltd from 2016 to 2025. This chart illustrates how Bio-Thera Solutions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Bio-Thera Solutions Ltd stock price today for real-time trading data and today's change.

Bio-Thera Solutions Ltd Cash Flow Conversion Ratio Explained

Bio-Thera Solutions Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Bio-Thera Solutions Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-Thera Solutions Ltd ranked by their cash flow conversion efficiency. Also see Bio-Thera Solutions Ltd (688177) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Ningbo Menovo Pharm Co Ltd SHG:603538	0.013x
Guangdong Fuxin Technology Co. Ltd. A SHG:688662	0.070x
180 Life Sciences Corp NASDAQ:ATNF	-0.037x
Suzhou Good-Ark Electronics Co Ltd SHE:002079	0.025x
Waypoint REIT AU:WPR	0.029x
Shenzhen Clou Electronics Co Ltd SHE:002121	0.146x
Sino Geophysical SHE:300191	0.017x
Shanghai Taisheng Wind Power SHE:300129	0.049x

Annual Cash Flow Conversion Efficiency for Bio-Thera Solutions Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Bio-Thera Solutions Ltd from 2016 to 2025. Review free cash flow generation of Bio-Thera Solutions Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥376.03 Million ≈ $55.03 Million	CN¥-82.11 Million ≈ $-12.02 Million	-0.218x	-177.83%
2024-12-31	CN¥708.09 Million ≈ $103.62 Million	CN¥-55.65 Million ≈ $-8.14 Million	-0.079x	+79.32%
2023-12-31	CN¥1.21 Billion ≈ $177.46 Million	CN¥-460.87 Million ≈ $-67.44 Million	-0.380x	-47.96%
2022-12-31	CN¥1.61 Billion ≈ $235.19 Million	CN¥-412.82 Million ≈ $-60.41 Million	-0.257x	-326.93%
2021-12-31	CN¥2.09 Billion ≈ $305.47 Million	CN¥236.27 Million ≈ $34.57 Million	0.113x	+163.40%
2020-12-31	CN¥2.01 Billion ≈ $293.48 Million	CN¥-358.04 Million ≈ $-52.39 Million	-0.179x	+81.17%
2019-12-31	CN¥630.67 Million ≈ $92.29 Million	CN¥-597.98 Million ≈ $-87.50 Million	-0.948x	-43.83%
2018-12-31	CN¥801.32 Million ≈ $117.26 Million	CN¥-528.25 Million ≈ $-77.30 Million	-0.659x	+3.20%
2017-12-31	CN¥347.55 Million ≈ $50.86 Million	CN¥-236.68 Million ≈ $-34.63 Million	-0.681x	-213.27%
2016-12-31	CN¥534.43 Million ≈ $78.20 Million	CN¥-116.18 Million ≈ $-17.00 Million	-0.217x	--

About Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology

Market Cap

$1.08 Billion

CN¥7.36 Billion CNY

Market Cap Rank

#8283 Global

#1887 in China

Share Price

CN¥17.77

Change (1 day)

-0.28%

52-Week Range

CN¥16.10 - CN¥26.71

All Time High

CN¥71.90